Description

3-(Methoxycarbonyl)-5-((4-Nitrobenzyloxy)Carbonyl)-4,5,6,7-Tetrahydropyrazolo[1,5-A]Pyrazine-2-Carbo is a high-purity, advanced pharmaceutical intermediate characterized by its complex heterocyclic structure. This compound is critical for research and development in medicinal chemistry, particularly in the synthesis of novel active pharmaceutical ingredients (APIs) targeting a range of therapeutic areas. It is primarily sought by pharmaceutical R&D laboratories, fine chemical manufacturers, and academic research institutions engaged in drug discovery programs.

Application

• Pharmaceutical Intermediate: Serves as a key building block in the synthesis of complex drug candidates, particularly those containing fused pyrazolo-pyrazine scaffolds.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization processes to develop new therapeutic agents.
• API Development: Employed in the research-scale and pilot-scale production of potential Active Pharmaceutical Ingredients (APIs).
• Chemical Biology Probes: Can be utilized to create specialized molecular probes for studying biological pathways and target validation.
• Custom Synthesis: A valuable starting material for contract research and manufacturing organizations (CROs/CMOs) offering bespoke chemical synthesis services.

Basic Information

Product Name	3-(Methoxycarbonyl)-5-((4-Nitrobenzyloxy)Carbonyl)-4,5,6,7-Tetrahydropyrazolo[1,5-A]Pyrazine-2-Carbo
CAS No.	1255574-57-2
Molecular Formula	C17H16N4O7
Molecular Weight	388.34 g/mol
Synonyms	Methyl 5-((4-nitrobenzyloxy)carbonyl)-2-carboxy-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine-3-carboxylate; 3-Carbomethoxy-5-((4-nitrobenzyloxy)carbonyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine-2-carboxylic acid; 1255574-57-2; Pyrazolo[1,5-a]pyrazine-2-carboxylic acid derivative; Tetrahydropyrazolopyrazine intermediate; 4-Nitrobenzyl protected pyrazolopyrazine ester.
EINECS	Contact for details

Quality Control

Our production of this advanced intermediate adheres to stringent quality management protocols. Each batch is subjected to comprehensive analytical testing, including HPLC for purity and identity confirmation and NMR for structural verification, to ensure it meets the exacting standards required for pharmaceutical R&D. A detailed Certificate of Analysis (COA) providing batch-specific data is supplied with every order to guarantee traceability and consistency.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). The container should be kept in a well-ventilated area and protected from moisture. For long-term storage, consider inert gas purging.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (HPLC)	Conforms
Identification (IR)	Conforms
Purity (HPLC)	≥ 97.0%
Related Substances (HPLC)	Individual impurity ≤ 1.0%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Water Content (KF)	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.